Page 676 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

654 PART IV Specific Malignancies in the Small Animal Patient

12. Higuchi T, Burcham GN, Childress MO, et al.: Characterization 32. Ricardo Huppes R, Crivellenti LZ, Barboza De Nardi A, et al.:
and treatment of transitional cell carcinoma of the abdominal wall Radical cystectomy and cutaneous ureterostomy in 4 dogs with tri-
in dogs: 24 cases (1985-2010), J Am Vet Med Assoc 242:499–506, gonal transitional cell carcinoma: description of technique and case
VetBooks.ir 13. Bryan JN, Keeler MR, Henry CJ, et al.: A population study of 33. Boston S, Singh A: Total cystectomy for treatment of transitional
series, Vet Surg 46:111–119, 2017.
2013.
neutering status as a risk factor for canine prostate cancer, Prostate
67:1174–1181, 2007. cell carcinoma of the urethra and bladder trigone in a dog, Vet Surg
43:294–300, 2014.
14. Glickman LT, Raghavan M, Knapp DW, et al.: Herbicide expo- 34. Wongsetthachai P, Pramatwinai C, Banlunara W, et al.: Urinary
sure and the risk of transitional cell carcinoma of the urinary blad- bladder wall substitution using autologous tunica vaginalis in male
der in Scottish Terriers, J Am Vet Med Assoc 224:1290–1297, 2004. dogs, Res Vet Sci 90:156–159, 2011.
15. Raghavan M, Knapp DW, Dawson MH, et al.: Topical flea and tick 35. Beck AL, Grierson JM, Ogden DM, et al.: Outcome of and com-
pesticides and the risk of transitional cell carcinoma of the urinary plications associated with tube cystostomy in dogs and cats: 76
bladder in Scottish Terriers, J Am Vet Med Assoc 225:389–394, 2004. cases (1995-2006), J Am Vet Med Assoc 230:1184–1189, 2007.
16. Raghavan M, Knapp DW, Bonney PL, et al.: Evaluation of the 36. Bray JP, Doyle RS, Burton CA: Minimally invasive inguinal
effect of dietary vegetable consumption on reducing risk of tran- approach for tube cystostomy, Vet Surg 38:411–416, 2009.
sitional cell carcinoma of the urinary bladder in Scottish Terriers, 37. Zhang J-T, Wang H-B, Shi J, et al.: Laparoscopy for percutaneous
J Am Vet Med Assoc 227:94–100, 2005. tube cystostomy in dogs, J Am Vet Med Assoc 236:975–977, 2010.
17. Decker B, Parker HG, Dhawan D, et al.: Homologous mutation 38. Berent AC: Ureteral obstructions in dogs and cats: a review of tra-
to human BRAF V600E is common in naturally occurring canine ditional and new interventional diagnostic and therapeutic options,
bladder cancer, evidence for a relevant model system and urine- J Vet Emerg Crit Care (San Antonio) 21:86–103, 2011.
based diagnostic test, Mol Cancer Res 13:993–1002, 2015. 39. Weisse C, Berent A, Todd K, et al.: Evaluation of palliative stenting
18. Mochizuki H, Shapiro SG, Breen M: Detection of BRAF mutation for management of malignant urethral obstructions in dogs, J Am
in urine DNA as a molecular diagnostic for canine urothelial and Vet Med Assoc 229:226–234, 2006.
prostatic carcinoma, Scarpa A, ed PLoS One 10:e0144170, 2015. 40. Blackburn AL, Berent AC, Weisse CW, et al.: Evaluation of
19. Mochizuki H, Shapiro SG, Breen M: Detection of copy number outcome following urethral stent placement for the treatment
imbalance in canine urothelial carcinoma with droplet digital poly- of obstructive carcinoma of the urethra in dogs: 42 cases (2004-
merase chain reaction, Vet Pathol 53:764–772, 2016. 2008), J Am Vet Med Assoc 242:59–68, 2013.
20. Deschamps J-Y, Roux FA: Extravesical textiloma (gossypiboma) 41. McMillan SK, Knapp DW, Ramos-Vara JA, et al.: Outcome of
mimicking a bladder tumor in a dog, J Am Anim Hosp Assoc 45:89– urethral stent placement for management of urethral obstruction
92, 2009. secondary to transitional cell carcinoma in dogs: 19 cases (2007-
21. Böhme B, Ngendahayo P, Hamaide A, et al.: Inflammatory pseu- 2010), J Am Vet Med Assoc 241:1627–1632, 2012.
dotumours of the urinary bladder in dogs resembling human 42. Radhakrishnan A: Urethral stenting for obstructive uropathy utiliz-
myofibroblastic tumours: a report of eight cases and comparative ing digital radiography for guidance: feasibility and clinical out-
pathology, Vet J 183:89–94, 2010. come in 26 dogs, J Vet Intern Med 31:427–433, 2017.
22. Martinez I, Mattoon JS, Eaton KA, et al.: Polypoid cystitis in 17 43. Berent AC, Weisse C, Beal MW, et al.: Use of indwelling, double-
dogs (1978-2001), J Vet Intern Med 17:499–509, 2003. pigtail stents for treatment of malignant ureteral obstruction in
23. Childress MO, Adams LG, Ramos-Vara J, et al.: Comparison of dogs: 12 cases (2006-2009), J Am Vet Med Assoc 238:1017–1025,
cystoscopy vs surgery in obtaining diagnostic biopsy specimens 2011.
from dogs with transitional cell carcinoma of the urinary bladder 44. Upton ML, Tangner CH, Payton ME: Evaluation of carbon diox-
and urethra, J Am Vet Med Assoc 239:350–356, 2011. ide laser ablation combined with mitoxantrone and piroxicam
24. Vignoli M, Rossi F, Chierici C, et al.: Needle tract implantation treatment in dogs with transitional cell carcinoma, J Am Vet Med
after fine needle aspiration biopsy (FNAB) of transitional cell car- Assoc 228:549–552, 2006.
cinoma of the urinary bladder and adenocarcinoma of the lung, 45. Cerf DJ, Lindquist EC: Palliative ultrasound-guided endoscopic
Schweiz Arch Tierheilkd 149:314–318, 2007. diode laser ablation of transitional cell carcinomas of the lower uri-
25. Hume C, Seiler G, Porat-Mosenco Y, et al.: Cystosonographic mea- nary tract in dogs, J Am Vet Med Assoc 240:51–60, 2012.
surements of canine bladder tumours, Vet Comp Oncol 8:122–126, 46. Parfitt SL, Milner RJ, Salute ME, et al.: Radiosensitivity and capac-
2010. ity for radiation-induced sublethal damage repair of canine transi-
26. Honkisz SI, Naughton JF, Weng HY: Evaluation of two-dimen- tional cell carcinoma (TCC) cell lines, Vet Comp Oncol 9:232–240,
sional ultrasonography and computed tomography in the mapping 2011.
and measuring of canine urinary bladder tumors, Vet J 232:23–26, 47. Arthur JJ, Kleiter MM, Thrall DE, et al.: Characterization of nor-
2018. mal tissue complications in 51 dogs undergoing definitive pelvic
27. Rippy SB, Gardner HL, Nguyen SM, et al.: A pilot study of toc- region irradiation, Vet Radiol Ultrasound 49:85–89, 2008.
eranib/vinblastine therapy for canine transitional cell carcinoma, 48. Poirier VJ, Forrest LJ, Adams WM, et al.: Piroxicam, mitoxantrone,
BMC Vet Res 257(12), 2016. and coarse fraction radiotherapy for the treatment of transitional
28. Naughton JF, Widmer WR, Constable PD, et al.: Accuracy of cell carcinoma of the bladder in 10 dogs: a pilot study, J Am Anim
three-dimensional and two-dimensional ultrasonography for mea- Hosp Assoc 40:131–136, 2004.
surement of tumor volume in dogs with transitional cell carcinoma 49. Nolan MW, Kogan L, Griffin LR, et al.: Intensity-modulated and
of the urinary bladder, Am J Vet Res 73:1919–1924, 2012. image-guided radiation therapy for treatment of genitourinary car-
29. Marvel SJ, Seguin B, Dailey DD, Thamm DH: Clinical outcome cinomas in dogs, J Vet Intern Med 26:987–995, 2012.
of partial cystectomy for transitional cell carcinoma of the canine 50. Choy K, Fidel J: Tolerability and tumor response of a novel low-
bladder, Vet Comp Oncol 15:1417–1427, 2017. dose palliative radiation therapy protocol in dogs with transitional
30. Hosoya K, Takagi S, Okumura M: Iatrogenic tumor seeding after cell carcinoma of the bladder and urethra, Vet Radiol Ultrasound
ureteral stenting in a dog with urothelial carcinoma, J Am Anim 57:341–351, 2016.
Hosp Assoc 49:262–266, 2013. 51. Yoshikawa H, Nolan MW, Lewis DW, et al.: Retrospective evalua-
31. Saeki K, Fujita A, Fujita N, et al.: Total cystectomy and subsequent tion of interfraction ureteral movement in dogs undergoing radia-
urinary diversion to the prepuce or vagina in dogs with transitional tion therapy to eluicidate appropriate setup margins, Vet Radiol
cell carcinoma of the trigone area: a report of 10 cases (2005-2011), Ultrasound 57:170–179, 2016.
Can Vet J 56:73–80, 2015.